Yingqiang Zhang

State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, No.1 Shuaifuyuan Wangfujing, Dongcheng District
Wangfujing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial.

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial.

Journal: BMC medicine

Published: August 18, 2025

Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers.

Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers.

Journal: Endocrine-related cancer

Published: January 29, 2025

BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials.

BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials.

Journal: Thyroid research

Published: October 27, 2024

Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer.

Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: October 15, 2023

Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone.

Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone.

Journal: Frontiers in endocrinology

Published: December 16, 2022

Characterization of Graves' disease development after partial thyroidectomy for thyroid cancer.

Characterization of Graves' disease development after partial thyroidectomy for thyroid cancer.

Journal: Translational cancer research

Published: March 24, 2021

Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas.

Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas.

Journal: Leukemia & lymphoma

Published: December 05, 2019

30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study.

30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study.

Journal: Endocrine

Published: May 01, 2018

Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis.

Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis.

Journal: European journal of radiology

Published: December 27, 2014

Primary pulmonary artery chondrosarcoma: the use of different imaging modalities.

Primary pulmonary artery chondrosarcoma: the use of different imaging modalities.

Journal: Chinese medical journal

Published: August 23, 2014

Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.

Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.

Journal: Chinese medical journal

Published: February 19, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026